| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2019.11.031 |
| P698 | PubMed publication ID | 31813649 |
| P2093 | author name string | Shuang Yu | |
| Kai Zhao | |||
| Mo Zhou | |||
| Zheng Jin | |||
| Xingye Yan | |||
| P2860 | cites work | Effective Charge Determination of Dendrigraft Poly-l-lysine by Capillary Isotachophoresis | Q59388966 |
| Hydrodynamic Behavior of Dendrigraft Polylysines in Water and Dimethylformamide | Q59388974 | ||
| The uptake and translocation of latex nanospheres and microspheres after oral administration to rats | Q69378917 | ||
| A novel bioadhesive intranasal delivery system for inactivated influenza vaccines | Q73447989 | ||
| Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination | Q84588291 | ||
| Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system | Q87760104 | ||
| A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy | Q88709246 | ||
| Harnessing the PEG-cleavable strategy to balance cytotoxicity, intracellular release and the therapeutic effect of dendrigraft poly-l-lysine for cancer gene therapy | Q91690199 | ||
| Dual aptamer modified dendrigraft poly-l-lysine nanoparticles for overcoming multi-drug resistance through mitochondrial targeting | Q91696983 | ||
| Sodium alginate: A biopolymeric catalyst for the synthesis of novel and known polysubstituted pyrano[3,2-c]chromenes | Q92775514 | ||
| Biomedical Applications of Chitosan and Its Derivative Nanoparticles | Q92979436 | ||
| Immune mechanisms of protection: can adjuvants rise to the challenge? | Q21245319 | ||
| Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery | Q26766552 | ||
| Vaccine Adjuvants: from 1920 to 2015 and Beyond | Q26783879 | ||
| Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems | Q26996159 | ||
| Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens | Q27310007 | ||
| Liposomes as nanomedical devices | Q28088315 | ||
| Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
| Molecular mechanisms for enhanced DNA vaccine immunogenicity. | Q30366743 | ||
| Programming the magnitude and persistence of antibody responses with innate immunity | Q30400144 | ||
| Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. | Q30404206 | ||
| An expeditious multigram-scale synthesis of lysine dendrigraft (DGL) polymers by aqueous N-carboxyanhydride polycondensation | Q33520735 | ||
| Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists | Q33721641 | ||
| Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. | Q33760871 | ||
| Structure-based programming of lymph-node targeting in molecular vaccines | Q33800766 | ||
| Structure and design of polymeric surfactant-based drug delivery systems | Q34343009 | ||
| Biomaterials for nanoparticle vaccine delivery systems | Q34345012 | ||
| Chitin and chitosan preparation from marine sources. Structure, properties and applications | Q34465615 | ||
| A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis | Q34500826 | ||
| A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge. | Q34700706 | ||
| Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles | Q35080032 | ||
| Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination | Q35192883 | ||
| Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction | Q35709003 | ||
| Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. | Q35836140 | ||
| Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen. | Q35887551 | ||
| VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells | Q36161076 | ||
| Polymer based drug delivery systems for mycobacterial infections | Q36320709 | ||
| Review. Hyaluronan: a powerful tissue engineering tool. | Q36591594 | ||
| Micellar nanocarriers: pharmaceutical perspectives | Q36655007 | ||
| Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. | Q37010485 | ||
| Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose | Q37126611 | ||
| Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles. | Q37184111 | ||
| Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. | Q37473416 | ||
| Nanomicellar formulations for sustained drug delivery: strategies and underlying principles | Q37731548 | ||
| Poly(anhydride) nanoparticles as adjuvants for mucosal vaccination | Q37762031 | ||
| Principles of vaccine design-Lessons from nature | Q37780346 | ||
| Hyaluronan, a ready choice to fuel regeneration: a mini-review | Q38046000 | ||
| Nanoparticle vaccines | Q38167942 | ||
| Alginate drug delivery systems: application in context of pharmaceutical and biomedical research | Q38238527 | ||
| ε-Polylysine and next-generation dendrigraft poly-L-lysine: chemistry, activity, and applications in biopharmaceuticals | Q38588588 | ||
| Digitizing Poly-L-lysine Dendrigrafts: From Experimental Data to Molecular Dynamics Simulations | Q38602357 | ||
| Elastic liposomes as novel carriers: recent advances in drug delivery. | Q38648991 | ||
| Recent advances in vaccine delivery. | Q38669255 | ||
| PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity | Q38692217 | ||
| Thiolated methylated dimethylaminobenzyl chitosan: A novel chitosan derivative as a potential delivery vehicle | Q38729983 | ||
| Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review | Q38742823 | ||
| Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants. | Q38757220 | ||
| Preparation methods and applications behind alginate-based particles | Q38918979 | ||
| Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvants | Q38953988 | ||
| Cationic Solid Lipid Nanoparticles Loaded by Cystein Proteinase Genes as a Novel anti-Leishmaniasis DNA Vaccine Delivery System: Characterization and in vitro Evaluations | Q38976665 | ||
| A bacteria deriving peptide modified dendrigraft poly-l-lysines (DGL) self-assembling nanoplatform for targeted gene delivery | Q38981358 | ||
| Biodegradable nanoparticles composed of dendrigraft poly-L-lysine for gene delivery. | Q38996726 | ||
| Novel biodegradable nanocarriers for enhanced drug delivery | Q39005331 | ||
| Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy. | Q39090297 | ||
| Choline transporter-targeting and co-delivery system for glioma therapy | Q39102426 | ||
| Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury | Q39106584 | ||
| Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity | Q39139577 | ||
| In vitro transfection mediated by dendrigraft poly(L-lysines): the effect of structure and molecule size. | Q39227454 | ||
| Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres. | Q39745470 | ||
| Interaction and transport of poly(L-lysine) dendrigrafts through liposomal and cellular membranes: the role of generation and surface functionalization | Q40078585 | ||
| Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon-specific drug delivery systems | Q40814895 | ||
| Design and Development of Immunomodulatory Antigen Delivery Systems Based on Peptide/PEG-PLA Conjugate for Tuning Immunity | Q40949331 | ||
| Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro | Q41611414 | ||
| Preparation of calcium alginate nanoparticles using water-in-oil (W/O) nanoemulsions. | Q41614163 | ||
| A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms | Q41879397 | ||
| Arginine end-functionalized poly(L-lysine) dendrigrafts for the stabilization and controlled release of insulin | Q42924809 | ||
| Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice | Q43623067 | ||
| Preliminary studies on the development of IgA-loaded chitosan-dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens | Q44354579 | ||
| Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery | Q44985757 | ||
| Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo | Q45109709 | ||
| Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier | Q45324303 | ||
| Study of interactions between oppositely charged dendrigraft poly-L-lysine and human serum albumin by continuous frontal analysis capillary electrophoresis and fluorescence spectroscopy | Q45886541 | ||
| Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. | Q45962430 | ||
| Adjuvanticity effect of sodium alginate on subcutaneously injected BCG in BALB/c mice | Q46182545 | ||
| Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally | Q46918824 | ||
| Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza. | Q46971184 | ||
| Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype | Q47097020 | ||
| Size optimization and in vitro biocompatibility studies of chitosan nanoparticles | Q47194210 | ||
| Everything you always wanted to know about poly-L-lysine dendrigrafts (but were afraid to ask). | Q47442062 | ||
| Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration. | Q47446657 | ||
| Antimicrobial Chitosan and Chitosan Derivatives: A Review of the Structure-Activity Relationship | Q47937753 | ||
| An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery | Q47961163 | ||
| Chemical Modification of Chitosan for Efficient Vaccine Delivery. | Q49693828 | ||
| Vaccine adjuvants: smart components to boost the immune system | Q50063256 | ||
| Chitosan and its derivatives as vehicles for drug delivery | Q50073720 | ||
| Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in black seabream Acanthopagrus schlegelii Bleeker to protect from Vibrio parahaemolyticus. | Q50471638 | ||
| Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading. | Q50791134 | ||
| Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery. | Q51750508 | ||
| PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection. | Q52648767 | ||
| Recent Advances in Polyanhydride Based Biomaterials. | Q52715707 | ||
| Nasal delivery of chitosan/alginate nanoparticle encapsulated bee (Apis mellifera) venom promotes antibody production and viral clearance during porcine reproductive and respiratory syndrome virus infection by modulating T cell related responses. | Q54206425 | ||
| Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice | Q56363239 | ||
| Preparation of self-assembled nanoparticles of ε-polylysine-sodium alginate: A sustained-release carrier for antigen delivery | Q56561231 | ||
| Physico-chemical characterization of Ca-alginate microparticles produced with different methods | Q57084461 | ||
| Production and characterization of hyaluronic acid microparticles for the controlled delivery of growth factors using a spray/dehydration method | Q57170482 | ||
| Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice | Q59274673 | ||
| Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection | Q59274675 | ||
| P433 | issue | 5 | |
| P921 | main subject | biodegradation | Q696715 |
| nanomaterial | Q967847 | ||
| P304 | page(s) | 1096-1104 | |
| P577 | publication date | 2019-12-06 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | An overview of biodegradable nanomaterials and applications in vaccines | |
| P478 | volume | 38 |
Search more.